“…However, another study carried out by Ren et al (74) stated the opposite result-that circ-ITCH had lower expression in OSA cells and was identified in clinical human OSA and para-tumor tissues. Their data showed that overexpression of circ-ITCH led to reduced SP-1 expression via PTEN/phosphoinositide 3-kinase (PI3K)/AKT pathways, which in turn suppressed proliferation, migration, and invasion by downregulating miR-22 (74). This is in concert with the conclusion that circ-ITCH might serve as an anti-oncogene via sponging multiple oncogenic miRNAs in multiple tumors, including ovarian cancer, prostate cancer, melanoma, gastric cancer, glioma, breast cancer, bladder cancer, papillary thyroid cancer, lung cancer, hepatocellular carcinoma, esophageal squamous cell carcinoma, and colorectal cancer (91,92).…”